was therefore, 46,XX,r(13),t(2 ;6)(q24;p22),fra(16q21)mat (figure). Structural or numerical chromosomal anomalies, increased abortion rate, and malformation syndromes without karyotype anomalies may be associated with fragile sites more often than suspected.3 Previous observations and this case must lead us to regard the chromosome 16 fragile site as a risk factor for de novo chromosomal abnormalities. The presence of a fragile site might be the result of the expression of a gene responsible for increased chromosomal instability and therefore a tendency to produce breaks. In our case at least four independent breakages might be suspected. The history of a previous abortion is also noteworthy.
It may be prudent to carry out fetal karyotype analysis whenever one of the parents is a known carrier of a fragile site. Moreover, fragile sites should be tested for in all de novo chromosomal abnormalities and particularly in those with more complex rearrangements.
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